Cognoa Autism Spectrum Disorder (ASD) Digital Therapeutic Engagement and Usability Study
Stopped early · Not applicable
Conditions studied: Autism Spectrum Disorder
In brief
Cognoa will measure usability, engagement with the device, and changes in parent-reported socialization during a 4-week period of intervention at home with the Cognoa ASD therapeutic device.
Key facts
- Study ID
- NCT04326231
- Run by
- Cognoa, Inc.
- People needed
- 10
- Starts
- 2020-03-17
- Expected to finish
- 2020-07-31
- Last updated by the study team
- 2023-09-21
Who can join
Age: 3 and older, up to 8. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Functional English language capability in the home environment.
- Parent, Guardian, or legal authorized representative (LAR) must be able to read, understand and sign the Informed Consent Form (ICF)
- Female or Male, > 3 to < 9 years of age and parent/caregiver
- Diagnosis of Autism Spectrum Disorder, within the last 12 months
- Parent, Guardian, or legal authorized representative (LAR) must have smartphone capabilities for downloading Testflight software; test versions of the Cognoa for Child development app; and test versions of the Cognoa Digital Therapeutic app (iOS 12.0 and up and Apple iPhone 8 and higher)
You may not qualify if…
- Participants with any other medical, behavioral, or developmental condition that in the opinion of the investigator may confound study data/assessments.
- Participants with planned extensive travel (more than 1 week) during the course of the 4 week intervention time period.
- Participants with deafness or blindness.
- Participants with known physical impairments affecting their ability to use their hands.
- Participants with active diagnosis of epilepsy and uncontrolled seizures.
- Participants whose age on the date of enrollment is outside the target age range
Where it is running
- Cognoa — Palo Alto, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.